260 related articles for article (PubMed ID: 10802793)
1. Oral zolmitriptan is effective in the acute treatment of cluster headache.
Bahra A; Gawel MJ; Hardebo JE; Millson D; Breen SA; Goadsby PJ
Neurology; 2000 May; 54(9):1832-9. PubMed ID: 10802793
[TBL] [Abstract][Full Text] [Related]
2. Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study.
Rapoport AM; Mathew NT; Silberstein SD; Dodick D; Tepper SJ; Sheftell FD; Bigal ME
Neurology; 2007 Aug; 69(9):821-6. PubMed ID: 17724283
[TBL] [Abstract][Full Text] [Related]
3. Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies.
Hedlund C; Rapoport AM; Dodick DW; Goadsby PJ
Headache; 2009 Oct; 49(9):1315-23. PubMed ID: 19788472
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study.
Cittadini E; May A; Straube A; Evers S; Bussone G; Goadsby PJ
Arch Neurol; 2006 Nov; 63(11):1537-42. PubMed ID: 16966497
[TBL] [Abstract][Full Text] [Related]
5. Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group.
Rapoport AM; Ramadan NM; Adelman JU; Mathew NT; Elkind AH; Kudrow DB; Earl NL
Neurology; 1997 Nov; 49(5):1210-8. PubMed ID: 9371896
[TBL] [Abstract][Full Text] [Related]
6. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
Tuchman M; Hee A; Emeribe U; Silberstein S
CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
[TBL] [Abstract][Full Text] [Related]
8. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
Dodick D; Brandes J; Elkind A; Mathew N; Rodichok L
CNS Drugs; 2005; 19(2):125-36. PubMed ID: 15697326
[TBL] [Abstract][Full Text] [Related]
9. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
Dowson AJ; Charlesworth BR; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group.
Solomon GD; Cady RK; Klapper JA; Earl NL; Saper JR; Ramadan NM
Neurology; 1997 Nov; 49(5):1219-25. PubMed ID: 9371897
[TBL] [Abstract][Full Text] [Related]
11. Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet.
Spierings EL; Rapoport AM; Dodick DW; Charlesworth B
CNS Drugs; 2004; 18(15):1133-41. PubMed ID: 15581383
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy of zolmitriptan and sumatriptan: issues in migraine trial design.
Geraud G; Olesen J; Pfaffenrath V; Tfelt-Hansen P; Zupping R; Diener HC; Sweet R
Cephalalgia; 2000 Feb; 20(1):30-8. PubMed ID: 10817444
[TBL] [Abstract][Full Text] [Related]
13. Zolmitriptan: a review of its use in migraine.
Spencer CM; Gunasekara NS; Hills C
Drugs; 1999 Aug; 58(2):347-74. PubMed ID: 10473025
[TBL] [Abstract][Full Text] [Related]
14. Zolmitriptan is effective for the treatment of persistent and recurrent migraine headache.
Mauskop A; Farkkila M; Hering-Hanit R; Rapoport A; Warner J
Curr Med Res Opin; 1999; 15(4):282-9. PubMed ID: 10640260
[TBL] [Abstract][Full Text] [Related]
15. A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine.
Gallagher RM; Dennish G; Spierings EL; Chitra R
Headache; 2000 Feb; 40(2):119-28. PubMed ID: 10759911
[TBL] [Abstract][Full Text] [Related]
16. Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study.
van Vliet JA; Bahra A; Martin V; Ramadan N; Aurora SK; Mathew NT; Ferrari MD; Goadsby PJ
Neurology; 2003 Feb; 60(4):630-3. PubMed ID: 12601104
[TBL] [Abstract][Full Text] [Related]
17. A long-term study to maximise migraine relief with zolmitriptan.
Tepper SJ; Donnan GA; Dowson AJ; Bomhof MA; Elkind A; Meloche J; Fletcher PE; Millson DS
Curr Med Res Opin; 1999; 15(4):254-71. PubMed ID: 10640258
[TBL] [Abstract][Full Text] [Related]
18. Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents.
Rothner AD; Wasiewski W; Winner P; Lewis D; Stankowski J
Headache; 2006 Jan; 46(1):101-9. PubMed ID: 16412157
[TBL] [Abstract][Full Text] [Related]
19. Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study.
Geraud G; Compagnon A; Rossi A;
Eur Neurol; 2002; 47(2):88-98. PubMed ID: 11844897
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of zolmitriptan nasal spray for the treatment of acute migraine in adolescents: Results of a randomized, double-blind, multi-center, parallel-group study (TEENZ).
Winner P; Farkas V; Štillová H; Woodruff B; Liss C; Lillieborg S; Raines S;
Headache; 2016 Jul; 56(7):1107-19. PubMed ID: 27329280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
